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Introduction 
The Population Council (through the STEP UP consortium and the Evidence Project) and the High Impact 
Practices (HIP) Collaboration, together with other partners, held a series of three consultative meetings 
around the topic of standards of evidence in reproductive and maternal health. The first consultation was 
held in New York (18-19 June 2013) and focused on the generation and synthesis of evidence to inform the 
production of HIP briefs. The second consultation was held in Croydon, UK (18-19 September 2013) and 
brought together researchers and funders of research to discuss and develop recommendations to improve 
research design and methodologies to generate evidence on the implementation and impact of FP/RH 
interventions; review mechanisms and structures for this evidence; and maximize quality and utility of 
evidence generation. 
The third and final meeting in the series was held in Bellagio, Italy from 9-11 February 2016. The meeting 
brought together developing country decision-makers (see Annex B for participant list) to vet, from the 
research “consumer” perspective, the recommendations that emerged from the second consultation and to 
elicit further recommendations on how to better generate and package evidence to meet the needs of 
decision-makers. Also in attendance were donors, multi-lateral organizations, and researchers from the 
second consultation, so that they could better understand the decision-makers’ perspectives and to forge 
connections between “producers” and “consumers” of evidence. 
Objectives 
Nineteen developing country decision-makers, representatives of donors and multi-lateral organizations, and 
researchers participated in the two-and-a-half day meeting. The meeting was structured in a participatory 
format, with a moderator initiating and facilitating discussion among participants. Most session moderators 
were country decision-makers. 
The goals of the Bellagio meeting were to: 
§ Share with national decision-makers the recommendations for standards of evidence developed 
during the two previous consultations, including types of studies, to determine their applicability in 
developing country contexts; 
§ Understand with greater insight how research evidence, along with other types of evidence, is 
currently used by national decision-makers and the factors facilitating or inhibiting use of evidence-
based best practice recommendations; 
§ Reach agreement on how research can be designed and implemented to best help national decision-
makers achieve their goals; 
§ Reach agreement on how research results can be synthesized, packaged, and communicated most 
appropriately for informing the various types of decisions made by national and sub-national health 
system stakeholders. 
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Key Points of Discussion 
On the first morning, to help frame the discussion, Dr. Ian Askew from the World Health Organization 
(WHO) provided a brief overview of the second consultation at Croyden and the relevant recommendations 
that emerged from that meeting (see Annex A for full agenda).  
Following this synopsis, Dr. Patrick Aboagye from the Ghana Health Service led a country decision-maker 
discussion on the topic of “policy and programs from the decision-maker perspective,” and the role for 
research-based evidence, with the intent of eliciting the decision-makers’ real life experiences and challenges 
around evidence use. An Evidence Project working paper titled “Family Planning Policy, Program, and 
Practice Decision-making: The Role of Research Evidence and Other Factors0F1” found that decision-makers 
often have a broader definition of “evidence” than researchers, that evidence tends to be just one of many 
factors in decision-making, and that evidence use is a non-linear process, with use occurring at various points 
in the decision-making process. Discussion among participants reinforced all of these points, particularly that 
evidence use is not always a uniform part of decision-making, but rather can occur at various stages and for 
various purposes in the decision-making process. For example, some decisions have to be made very quickly 
and there is not time for rigorous research designs to answer the question – decision-makers need to reach 
out to the most convenient, readily available source for evidence. In other instances, evidence is sought to 
justify continued investment in a decision that has already been made. These examples highlight the 
complexity and challenges of evidence-based decision-making. 
Key issues were raised around the themes of what types of evidence consumers want, as well as the time it 
takes to generate this evidence through research. Decision-makers made the point that they are often not 
looking for evidence from randomized controlled trials or systematic reviews, but operational evidence that 
can inform program investments and their implementation. A challenge for decision-makers as research 
consumers is the time required to conduct primary research that may be necessary to generate the 
information needed for them to use to improve programming.  
Decision-makers also raised the issue that politicians often look to them for very quick, evidence-informed 
answers to questions so that they can rapidly respond to issues arising in parliament or among their 
constituents. This presents a challenge, as undertaking research is not an option in these situations, given time 
constraints. Decision-makers need options to access rigorous evidence quickly to be able to respond to these 
requests. The group discussed existing examples of rapid response mechanisms, although the definition of 
“rapid” varies and it is not clear how sustainable these mechanisms are without donor funding. 
Another issue raised in this session is communication between researchers and decision-makers on how 
research agendas are identified, as well as on whether the results produced from research are relevant for 
decision-makers. It is important to balance research agendas of external donors who fund the studies to 
achieve their goals with those of country decision-makers who need the evidence to improve their programs. 
Research prioritization should start with dialogue between donors, researchers and policy makers so that 
those expected to use the evidence are aware of and understand the research being done - in the absence of 
dialogue and understanding, decision-makers can become barriers to conducting and using research, rather 
than champions. Dialogue would also help to align the research with country needs, thereby gaining buy-in 
from key end users. The discussion also highlighted many common challenges of ensuring that the research 
consumers have knowledge of and access to the results once the research is completed; for example, all 
                                                      
1 http://evidenceproject.popcouncil.org/wp-content/uploads/2015/09/Role-of-Evidence-Working-Paper.pdf 
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participants emphasized the importance of open access to journal publications to remove cost barriers to 
country end users.  
Decision-makers emphasized that the government needs to be closely connected to research from the 
beginning, so that scale up of the results is accepted as the responsibility of the government and not just a 
recommendation given to them at a dissemination meeting, with no plan for implementation. Sometimes 
decision-makers aren’t even aware of relevant research that was done in their country and only learn of it at a 
conference or similar venue, which shows a potential disconnect between producers and consumers of 
research. 
Following this discussion, key issues related to standards of evidence were discussed, with presentations by 
Karen Hardee of the Population Council and Director of the Evidence Project, Nhan Tran from the WHO, 
and Özge Tunçalp from the WHO.  
Dr. Hardee gave a presentation on “Standards and Types of Evidence for Clinical, Public Health, and 
Multisectoral Interventions.” She discussed the importance of using different study designs depending on the 
evidence needed, as they can answer different types of questions and add greater nuance to the evidence. For 
example, as shown in Figure 1, qualitative evidence is useful for assessing service delivery processes, 
acceptability, appropriateness, and service satisfaction, as it gets to people’s perceptions and adds important 
context to the quantitative data. 
FIGURE 1 | EXAMPLE OF A TYPOLOGY OF EVIDENCE FOR SOCIAL INTERVENTIONS 
FOR CHILDREN 
 
Dr. Hardee also stressed that researchers should be flexible in designing their studies in order to meet the 
needs of the end user (while retaining its rigor and high quality) and that the results should be implementable 
by national programs. Finally, she discussed what is known about how decision-makers use research evidence 
in the decision-making process, including how it is supplemented with other types of evidence, such as 
personal or professional experience and anecdotal evidence, and how research evidence is perceived through 
an individual’s beliefs and values, as well as external constraints, before a decision is made.  
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Dr. Tran then presented on using implementation research to inform scale up and improve program 
efficiency. He discussed the need for research to be more dynamic and iterative, rather than producing linear 
outputs, outcomes, and impact, since policy making and implementation is not always a rational, linear 
process. Echoing Dr. Hardee, he noted that it is incorrect to assume that there is a single solution to complex 
challenges, i.e. that one research design can answer multiple questions. Dr. Tran also made the point that 
implementation of research findings often has to be done with limited information. A report entitled 
“Enabling efficient policy implementation”1F2 found that poor implementation is widespread, with common 
reasons including poor planning, the complexity of consistent implementation, and push-back or lack of 
interest from health professionals responsible for implementation. Finally, research needs to take the social 
and political context and health systems into consideration, and take advantage of unexpected opportunities 
that may present themselves. 
Dr. Tunçalp closed the session by presenting on “From Evidence to Guidelines: what’s in an acronym?” She 
summarized the WHO guideline development process and the effort to make the guidelines more focused on 
questions not just of effectiveness, but also acceptability and feasibility, which are issues important to 
decision-makers. This was done through the development of the DECIDE (Developing and Evaluating 
Communication Strategies to Support Informed Decisions and Practice Based on Evidence) framework 
(which is complementary to the GRADE (Grading of Recommendations Assessment, Development and 
Evaluation) framework). In the WHO guideline development process, questions of efficacy and safety are 
answered with systematic reviews of controlled studies, while acceptability and feasibility are answered with 
systematic reviews of qualitative research. To answer the question of how decision-makers, who are often not 
themselves research experts, can be confident in the quality of evidence, particularly qualitative evidence, Dr. 
Tuncalp reviewed the GRADE CERQual (Confidence in the Evidence from Reviews of Qualitative research) 
process. Finally, the presentation closed with an overview of the ongoing process to help make global level 
guidelines more useful and easier to adapt and implement at the country level.  
Day one closed with a discussion of the role of politics and opinion in assessing standards of evidence, 
facilitated by Dr. Josephine Kibaru from the National Council for Population and Development in Kenya. 
The discussion covered a variety of challenges, including the need for consensus building and to engage a 
variety of politicians at different levels, not just the federal level. Increased decentralization makes this 
especially important: even if research results in a policy change at the federal level, implementation of the new 
policy could be hindered if sub-national level politicians and decision-makers were not involved, particularly if 
the change required is substantial. There can also be political challenges to bringing in evidence and 
experiences from other countries, as there can be sensitivity around which countries are used for comparison. 
Conversely, countries will often find global evidence insufficient and will want research on how a policy or 
intervention would work locally before implementation.  
A number of issues were cited related to the influence of political factors on evidence use in decision-making. 
This included frequent turnover of politicians at the highest levels of decision-making, though it was noted 
that engaging civil servants, who tend to stay in their positions for longer periods, can mitigate that. Political 
hierarchy can also hinder the use of research evidence in policy making since, for example, it can be difficult 
to ensure that research evidence is communicated effectively through the hierarchy to reach the highest levels 
of decision-making. Professional associations and nongovernmental organizations were mentioned as 
stakeholders that should be engaged to help overcome these challenges, as they can be very influential in the 
policy process. Another method to overcome political challenges is the identification of effective champions 
who can help to ensure that evidence and accurate information reaches politicians.  
                                                      
2 http://www.oracle.com/us/industries/public-sector/economist-report-193495.pdf 
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Day two opened with a discussion among country decision-makers, facilitated by Susan Elden from DfID, of 
their perspectives on country-level research agendas, research coordination, and challenges to evidence 
generation or access to evidence at the country level. It was agreed that decision-makers generally do not have 
the ability or time to determine the quality of research evidence on their own; discussion focused on if and 
how in-country arbiters of good and poor research methodology could help decision-makers assess the 
quality of evidence from national and international sources. Potential arbiters of research evidence included 
universities, professional associations, or technical working groups that have credibility. In Bangladesh, for 
example, professional associations are engaged in research review. Generally, it was agreed that there is not a 
one-size-fits-all solution and that each country needs to determine for themselves what entities could play this 
role. There was agreement, however, that decision-makers do need a mechanism to help them judge the 
quality of research, since the quality will impact the results. Discussion concluded with a conversation about 
whether more global guidance is needed to help country decision-makers assess the quality of evidence, 
similar to guidance2F3 that DfID has produced. 
Dr. Koku Awoonor-Williams from the Ghana Health Service facilitated a discussion among the researchers, 
multi-lateral representatives, and donors to discuss their perspectives on these topics, including if and how 
research needs to better align with country research agendas and how research can be better coordinated 
among all partners. This discussion also addressed the importance of donors having more of a culture of 
embedding research and learning into program implementation and a more diverse portfolio of research 
mechanisms (seed grants, grand challenges, implementation research, clinical trials, and so forth) to enable 
more country-level opportunities for different stakeholders to be involved in the research process.  
Discussion for the remainder of the second day covered packaging and communication of evidence. Three 
means of communicating evidence were reviewed and discussed (a single journal article, High Impact Practice 
briefs, and WHO global guidance) to gain decision-maker perspectives on the usefulness of these documents 
in their current form and what could be done to make them more understandable and accessible to encourage 
use. The discussion also focused on what types of evidence the decision-makers preferred, what they would 
like more of, and what they felt were the most effective methods of communicating evidence to decision-
makers. The importance of open access journals was reiterated, as the requirement to pay or have a 
subscription to access an article can be a hindrance for decision-makers to access evidence.  
Other important suggestions made by the decision-makers for how better to communicate evidence include: 
§ Presentations on research evidence to targeted sub-groups 
§ Use of concise summaries and plain language in communication of evidence 
§ Sending research reports (or briefs with key information from the report) to ministries 
§ Recognizing the varied information needs of different audiences and the importance of “marketing” 
evidence to different audiences, not just disseminating it 
§ Global-level web repositories or packaging of information to encourage access and collaboration 
§ Having research “teams” comprising those working on both the research and the 
use/communication of that research, and ensuring appropriate timing of engagement of all parties 
§ Using various means of communicating evidence including briefs, video, e-mail digests, etc.  
It was agreed that public health is the intersection of both politics and science, which reflects the idea that 
decision-makers and researchers should be working as partners to ensure that needed questions are being 
generated, that research asks these questions in the right way, and that the evidence generated will be used to 
translate research into practice.  
                                                      
3 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/291982/HTN-strength-evidence-
march2014.pdf 
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Recommendations 
The recommendations that emerged from the Bellagio consultation fall into four major categories: Global 
mechanisms, country mechanisms, implementation research and decision science (IRDS), and packaging and 
communication of evidence. 
I. GLOBAL MECHANISMS 
Among sources of evidence, the discussion highlighted that WHO global guidance is one of the most trusted, 
particularly when other sources of evidence are scarce. Country decision-makers recognize that national 
health systems see the value of and benefit from global guidance, particularly guidance developed by the 
WHO. However, it was also acknowledged that global guidance can’t answer every question, particularly 
when it comes to local context. 
a. The relevance and applicability of WHO guidance could be further strengthened by applying new methodologies for 
synthesizing and appraising a broader range of evidence, such as evidence from qualitative studies and complex 
interventions. 
The meeting participants also underscored a conclusion from the Croydon meeting that “different decisions 
require different types of evidence generated through different study designs; consequently the utility of 
research-based evidence will depend on its capacity to inform a particular decision.” The flexibility of having 
multiple study design options may better allow for non-traditional sources of evidence, such as grey literature, 
expert opinion, and implementation experience to be taken into account. This broad range of sources allows 
for a nuanced interpretation of evidence that can address a wider range of questions, such as: Who directly 
benefits from program investments? In what context? This also allows for the incorporation of additional 
dimensions such as scale and cost of intervention implementation. Taken together, WHO guidance and 
complementary sources of evidence may provide a more comprehensive interpretation for policy makers. 
b. We recognize that policy makers and program managers have a range of information needs that cannot be addressed 
with WHO guidance alone. Therefore, we stress the need for continued investment in complementary processes, 
resources, and capabilities at all levels for generating, synthesizing and communicating evidence. 
Inconsistent knowledge about and messaging of new research findings at the global and country levels can 
hamper evidence-based programming at the country level. 
c. Development partners including UN organizations must ensure alignment and consistency of messaging for research 
findings and results at the regional and country levels. 
At the country level, decision-makers are often faced with immediate or urgent needs for evidence or 
information. In these instances, there is no time for a study to generate evidence, and decision-makers are 
often left rushing to find relevant evidence in which they feel confident.  
d. Development partners should work with countries to explore the potential of response mechanisms designed to address 
information needs in a timely manner. 
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II. COUNTRY MECHANISMS 
Though global guidelines, recommendations, and platforms are important for evidence generation and use, 
action at the country level is critical. Numerous development partners invest in valuable research, however 
these efforts are not well-coordinated and results are not consistently communicated or made available at the 
country level. As a result, opportunities for utilization and scale up of research evidence are often missed. 
a. There is a need for coordination of research activities and organization of knowledge resources at the global and country 
levels. As a first priority, countries and development partners are encouraged to create a publicly accessible, searchable 
research repository at the national level. This repository would be managed and maintained by a relevant national 
organization. These organizations may require technical and/or financial assistance to strengthen their capacity to 
manage and maintain this repository. 
 
b. Governments and development partners are encouraged to support national and/or sub-national research symposiums, 
coordinated through the Ministry of Health and/or other relevant government bodies, to foster knowledge management 
and consensus building around research results and knowledge gaps. 
International synthesis and guidance, following standardized and agreed upon principles and procedures, 
provides a widely accepted consensus on research findings. However, to best serve the needs and address the 
unique challenges of countries at the national and sub-national levels, international guidance must be 
contextualized to the local situation, and countries need tools to help make policy and program decisions 
appropriate for local contexts. 
c. To implement evidence-based change, countries require consultative processes, resources, and capabilities for generating, 
synthesizing, and using locally appropriate evidence. Countries also need to be supported in adapting global guidelines 
for local use. 
 
d. Policy makers and program managers are encouraged to build local capacity for and use underutilized decision-making 
tools, such as Root Cause Analysis and Bottleneck Analysis, to better identify underlying causes of program constraints 
and bottlenecks. 
Leaders must then garner support for evidence-based policy and program change. 
e. Countries are encouraged to build capacity at the national and sub-national levels to use evidence-based 
strategies/mechanisms to garner support for policy and program change. Such strategies could include, but are not 
limited to, developing leadership within Ministries to advocate for change, identifying and supporting in-country 
champions, broadening stakeholder engagement, capacity building of policy makers and other key stakeholders for 
advocacy, and study tours. 
III. IMPLEMENTATION RESEARCH AND DELIVERY SCIENCE (IRDS) 
In order to meet national and international development goals, countries must move from pilot or 
demonstration projects that generate evidence of improved health service delivery and system improvements 
to nationwide implementation and institutionalization of high impact practices. 
a. To be most effective, scale-up of interventions with demonstrated effectiveness through pilot projects should include 
processes for continual learning and adaptation as scale-up proceeds, sometimes referred to as Implementation Research 
and Delivery Science (IRDS). 
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We recognize and applaud IRDS as a platform that brings together key development partners in an effort to 
introduce mechanisms to embed implementation research into policy making, program management, and 
monitoring and evaluation processes.  
b. To operationalize this effort, governments should consider embedding IRDS in national plans and policies. Countries 
are encouraged to start with a review of the Cape Town Statement on IRDS.3F4  
IV. COMMUNICATING AND PACKAGING EVIDENCE 
It is important that there is a plan to encourage the use of evidence that is generated. Packaging and 
communication are key elements of evidence use, so that the intended audiences receive the evidence in a 
clear and compelling way that will bring it into the multi-dimensional decision-making process and lead to 
evidence-based change.  
Access to evidence is a basic, yet not always simple, element of utilization. However there is a trend, 
particularly among the donor community and multi-lateral organizations, to ensure open access to journal 
articles – at a minimum for developing country audiences, who otherwise might not have the resources to 
access these journals. 
a. Recognizing the trend towards more open access, we encourage more journals to provide open access mechanisms and 
more researchers to publish in open access journals. To aid in operationalization of intervention research, we also 
encourage researchers and journals to include supplemental materials on the description of the intervention, beyond 
what space limitations make it possible to include in the article.  
b. WHO and development partners should raise awareness of the availability of free journal access through the 
HINARI website (who.int/HINARI) to health institutions in developing countries. 
Additionally, those using evidence to influence the decision-making process are not a homogenous group. 
They have diverse opinions, preferences for receiving messages about new evidence, and formats in which 
they prefer to have evidence delivered. 
c. To increase research utilization, researchers/research teams should segment audiences and settings by use of different 
messaging, tools, platforms, and packaging (e.g. multimedia, Twitter, listserv emails, HIP map). 
Finally, the responsibility for research utilization should not rest solely on the researcher. Research utilization 
should begin at the stage of question identification, involving those with a variety of expertise, including those 
who can help develop and plan for evidence use and those local stakeholders who can influence its use. 
d. Research proposals should include research utilization plans, and research teams should include members with a 
variety of skills who will help to translate the findings into action throughout the research process and not only at the 
end. 
e. Country programs will benefit from greater utilization of evidence and data for decision making. Therefore, policy 
makers and other local stakeholders should seek ways to incorporate research utilization into decision-making 
processes.  
                                                      
4 http://healthsystemsglobal.org/upload/hsg_media/statement_IRDS.pdf?view-version=1.0 
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Appendix 1 | Meeting Agenda 
TIME SESSION/OBJECTIVES DISCUSSION QUESTIONS/  KEY POINTS 
SESSION MODERATORS/ 
DISCUSSANTS 
TUESDAY FEBRUARY 9TH 
8:00 am – 
9:00 am BREAKFAST 
9:15 am – 
9:30 am 
Welcome, participant introductions, 
overview of the meeting, logistics  
MODERATORS 
Karen Hardee, Evidence 
Project/Population Council 
 
Harriet Birungi, STEP-
UP/Population Council  
9:30 am – 
10:15 am 
Objective 1 
Rationale and objectives for this 
consultation: 
§ Overview of previous 
consultations 
§ Contribution of this meeting to 
standards of evidence and 
rationale and expectations for 
this meeting 
§ Expected product outcomes 
§ Link this meeting to 
previous meetings to clarify 
rationale for this 
consultation 
§ Brief overview of 
recommendations from 
previous meetings 
§ Define products of meeting 
(audience, what will they 
look like?) 
MODERATORS 
Ian Askew, WHO 
 
Shawn Malarcher, USAID 
10:15 am – 
11:15 am 
 
Facilitated discussion among 
country decision-makers using 
questions from the pre-meeting 
survey 
 
Objective 2 
The world of policy and program 
from the decision-maker 
perspective: what is the role for 
research-based evidence, among 
other factors? 
§ Group-wide understanding of 
decision-making processes in 
diverse situations 
§ Examples of how and when 
research-based evidence is and 
is not used 
§ Key constraints in using 
evidence  
Role of research-based 
evidence in making decisions: 
§ What decisions are 
decision-makers faced with 
for which evidence could be 
helpful? 
§ How often are you faced 
with these decisions? 
§ What time frame do you 
have to make these 
decisions? (a week, month, 
etc.) 
§ Are there other 
constraints/parameters 
that influence decisions? 
§ How do decision-makers 
use evidence? (inform 
decisions, justify decisions, 
inform implementation) 
 
MODERATORS  
Patrick Aboagye, Ghana 
Health Service	
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TIME SESSION/OBJECTIVES DISCUSSION QUESTIONS/  KEY POINTS 
SESSION MODERATORS/ 
DISCUSSANTS 
§ What can producers of evidence 
do to make research more 
accessible/usable for decision-
makers? 
11:15 am – 
11:30 am BREAK 
11:30 am-
12:45 pm 
Continuation of discussion 
 
The world of policy and program 
decision-making; what is the role for 
research-based evidence, among 
other factors? 
§ Where do decision-makers 
go for input/advice? Why 
these sources? 
§ What are the key 
constraints to accessing 
and using research-based 
evidence? Which of these 
can be addressed by 
producers of evidence? 
MODERATORS 
Patrick Aboagye, Ghana 
Health Service 
12:45 pm –
2:15 pm LUNCH 
2:15 pm – 
3:45 pm 
Key issues related to standards of 
evidence. Short presentations and 
facilitated discussions on four 
issues. 
 
Issue 1: Standards and types of 
evidence for demonstrating 
effectiveness of ‘clinical,’ ‘public 
health,’ and multisectoral 
interventions 
 
Issue 2: Using Implementation 
Research to inform scale up and 
improve program efficiency 
 
Issue 3: Summarizing bodies of 
evidence: what’s behind the existing 
guideline acronyms? 
§ Articulate the differences 
between standards and 
types of evidence needed 
for ‘clinical’ and ‘public 
health’ RH/FP interventions 
and quality of evidence  
§ How is Implementation 
Research different than 
impact studies? What is the 
value added? 
§ Using different methods 
can yield different answers 
(impact assessments as 
well as systematic reviews) 
 
MODERATORS 
Issue 1: Karen Hardee, 
Evidence Project/ 
Population Council 
 
Issue 2: Nhan Tran, AHSPR 
 
Issue 3: Özge Tunçalp, 
WHO 
 
 
3:45 pm – 
4:00 pm BREAK 
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TIME SESSION/OBJECTIVES DISCUSSION QUESTIONS/  KEY POINTS 
SESSION MODERATORS/ 
DISCUSSANTS 
4:00 pm – 
4:45 pm 
Issue 4: What is the role of politics 
and expert opinion in assessing 
standards of evidence? 
 
MODERATOR 
Issue 4: Josephine Kibaru-
Mbae, NCPD, Kenya  
4:45 pm – 
5:15 pm 
Other issues in research evidence: 
cost data, quality of evidence, 
measuring sustainability  
Discussion of other issues that 
arise related to evidence, 
including questions about 
evidence from participants 
MODERATOR 
Kazuyo Machiyama, 
LSTHM 
7:00 pm – 
8:30 pm DINNER 
WEDNESDAY FEBRUARY 10TH 
8:00 am – 
9:00 am BREAKFAST 
9:15 am – 
9:25 am 
 
Recap of key points and highlights 
from Day 1 
 
MODERATOR  
Tapash Das, DGFP,	
Bangladesh 
9:25 am – 
9:45 am 
Finalize draft recommendations 
from Day 1 
Review and reach agreement 
on wording of the draft 
recommendation statements 
for objectives #1 and #2 
MODERATOR 
Ian Askew, WHO 
9:45 am –
10:45 am 
Objective 3 
Moderated discussion with decision-
makers 
 
 
What mechanisms does your 
ministry currently have in place 
to: 
§ Set and manage a research 
agenda 
§ Commission or otherwise 
fund research studies 
§ Coordinate and receive 
evidence from national 
universities / research 
organizations 
 
To what extent do these 
mechanisms include 
opportunities for the different 
types of research discussed on 
day 1? 
MODERATOR 
Susan Elden, DFID 
 
DISCUSSANTS 
Country decision-makers 
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TIME SESSION/OBJECTIVES DISCUSSION QUESTIONS/  KEY POINTS 
SESSION MODERATORS/ 
DISCUSSANTS 
How could these mechanisms 
be improved to generate the 
quality of evidence needed? 
 
10:45 am –
11:00 am BREAK 
11:00 am -
12:00 pm 
Moderated discussion with donors 
and researchers 
 
You’ve heard from the country 
decision-makers.  
§ What have your 
experiences been as 
donors, including both 
successes and challenges, 
in supporting country-led 
research?  
§ From the discussion we’ve 
had, can you think of ways 
that donors and the 
research programs they 
fund could better support 
countries to improve their 
mechanisms for generating 
and synthesizing research, 
and for using evidence to 
inform nationally-
appropriate programming? 
MODERATORS 
 
Koku Awoonor-Williams, 
Ghana Health Service 
 
DISCUSSANTS 
 
Representatives from 
USAID, DfID, WHO, UNFPA, 
the Evidence Project, Step-
Up Project 
12:00 pm – 
12:45 pm 
Objective 4 
 
Effective packaging and 
communication of evidence (Group 
discussion) 
 
Look at examples of evidence 
packaging and discuss how these 
formats could be made more useful 
for policy makers. 
 
 
§ What do you like about 
each format? What would 
you change and how? 
§ Does it include the 
information you need? 
§ Is it written in a way that is 
easy to understand and 
use? 
§ Where do you go to get 
information? 
MODERATORS 
Shawn Malarcher, USAID  
 
DISCUSSANTS 
MD Younus Mian, MOHFW, 
Bangladesh 
(journal article) 
 
Placid Mihayo, MOH, 
Uganda 
(FP HIPs) 
 
Chito Nelson, NPHCDA, 
Nigeria (WHO Task Shifting 
guidance) 
12:45 pm –
1:00 pm GROUP PHOTO 
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TIME SESSION/OBJECTIVES DISCUSSION QUESTIONS/  KEY POINTS 
SESSION MODERATORS/ 
DISCUSSANTS 
1:00 pm – 
2:15 pm LUNCH 
2:15 pm – 
3:45 pm 
Continue discussion on effective 
packaging and communication of 
evidence 
 MODERATOR Shawn Malarcher, USAID 
3:45 pm – 
4:00 pm BREAK 
4:00 pm – 
5:00 pm 
Address Parking Lot topics from 
prior two days  
MODERATOR 
Robin Keeley, Evidence 
Project/PATH 
7:00 pm – 
8:30 pm DINNER 
THURSDAY FEBRUARY 12TH 
8:00 am – 
9:00 am BREAKFAST 
9:15 am – 
9:25 am 
Recap of key points and highlights 
from Day 2  
MODERATOR 
Naeem Zafar, Ministry of 
Planning, Development & 
Reform, Pakistan 
9:25 am – 
9:45 am 
Finalize draft recommendations 
from Day 2 
Draft the agreed-upon 
recommendations as short, 
action-oriented bullet points 
that can be framed as a 
consensus statement 
MODERATOR 
Harriet Birungi, STEP-
UP/Population Council 
9:45 am – 
11:00 am 
 
Objective 5 
 
Preparing a consensus statement  
 
Group Discussion: Reflecting on the 
recommendations from the Croyden 
meeting, discuss key points of 
agreement from the consultation on 
standards of evidence from the 
perspective of decision-makers, 
including design and 
implementation of research to help 
Recommend processes to 
better align research with 
decision-makers’ needs 
MODERATORS 
Karen Hardee, Evidence 
Project/Population Council 
 
Shawn Malarcher, USAID 
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SESSION MODERATORS/ 
DISCUSSANTS 
decision-makers, and the synthesis, 
packaging and communication of 
research results to best reach 
decision-makers 
11:00 am –
11:15 am BREAK   
11:15 am – 
12:45 pm 
Final recommendations for the 
consensus statement. Discussion on 
plans for preparation of consensus 
statement and meeting report, 
including authorship and process for 
finalizing the report, publication and 
dissemination. 
 
Evaluation  
 
Wrap-up	
The purpose of the consensus 
statement is to inform and 
influence the funding, design, 
implementation and 
communication of research on 
reproductive and maternal 
health policies and programs in 
developing countries. 
MODERATORS 
Karen Hardee, Evidence 
Project/Population Council  
 
Harriet Birungi, STEP-
UP/Population Council 
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Appendix 2 | List of Participants 
NAME COUNTRY TITLE ORGANIZATON 
Mr. MD Younus Mian Bangladesh Deputy Chief (Planning Wing) 
Ministry of Health and 
Family Welfare 
Dr. Tapash Ranjan Das Bangladesh Deputy Director, MCH Directorate General of Family Planning 
Dr. Patrick Aboagye Ghana Director of Family Health Division  Ghana Health Service 
Dr. Koku Awoonor-
Williams Ghana 
Director of Policy Planning 
Monitoring & Evaluation Ghana Health Service 
Dr. Josephine Kibaru-
Mbae Kenya Director General 
National Council for 
Population and 
Development 
Mrs. Chito Nelson Nigeria Deputy Director (HSS) 
National Primary Health 
Care Development 
Agency 
Dr. Naeem-uz-Zafar Pakistan Member, Social Sectors & Devolution 
Ministry of Planning, 
Development & Reform 
Dr. Placid Mihayo Uganda Assistant Commissioner RH Ministry of Health 
Dr. Ian Askew Switzerland 
Director, Department of 
Reproductive Health and 
Research 
WHO 
Dr. Özge Tuncalp Switzerland Department of Reproductive Health and Research WHO 
Dr. Nhan Tran Switzerland Alliance for Health Policy and Systems Research  WHO 
Ms. Shawn Malarcher USA Senior Best Practices Utilization Advisor USAID 
Mr. Neal Brandes USA Research Advisor USAID 
Mrs. Susan Elden United Kingdom 
Health Adviser, Human 
Development Research 
Team, Research and 
Evidence Division 
DfID 
Dr. Karen Hardee USA Senior Associate and Project Director 
The Evidence Project, 
Population Council 
Ms. Robin Keeley USA Research Utilization Specialist 
The Evidence Project, 
PATH 
Dr. Harriet Birungi Kenya 
Kenya Population Council 
Country Director and Project 
Director  
STEP UP Project, 
Population Council 
Dr. Kazuyo Machiyama United Kingdom Faculty  
London School of 
Hygiene & Tropical 
Medicine 
Dr. Eugene Kongnyuy DRC H4+ Coordinator and Chief Technical Advisor UNFPA 
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